background
littl
known
postinfecti
pulmonari
sequela
countri
like
cambodia
tuberculosi
hyperendem
childhood
pulmonari
infect
highli
frequent
describ
characterist
hospit
cambodian
patient
present
communityacquir
acut
lower
respiratori
infect
alri
postinfecti
pulmonari
sequela
alrip
method
inpati
year
alri
prospect
recruit
clinic
biolog
radiolog
microbiolog
data
collect
chest
radiograph
reinterpret
expert
compar
patient
alrip
previous
healthi
lung
alrihl
activ
pulmonari
tuberculosi
tb
patient
without
chest
radiograph
abnorm
abnorm
suggest
chronic
respiratori
diseas
exclud
analysi
result
among
inpati
communityacquir
alri
elig
alrip
alrihl
tb
alrip
patient
less
frequent
fever
alri
p
product
cough
alrihl
p
streptococcu
respiratori
medicin
pneumonia
haemophilu
influenza
pseudomona
aeruginosa
account
alrip
group
posit
cultur
h
influenza
p
aeruginosa
significantli
associ
alrip
compar
alrihl
treatment
appropri
alrip
patient
final
alrip
recogn
local
clinician
inhospit
mortal
low
probabl
underestim
alrip
group
conclus
alrip
remain
often
misdiagnos
tb
inappropri
treatment
lowincom
countri
bettertarget
train
program
would
help
reduc
morbid
burden
financi
cost
acut
lower
respiratori
infect
lung
sequela
cambodia
neglect
diseas
highli
tuberculosisendem
countri
introduct
unit
nation
millennium
develop
goal
aim
revers
tuberculosi
tb
epidem
despit
clear
reduct
tb
incid
posttb
pulmonari
sequela
remain
underrecogn
countri
direct
link
number
tb
episod
lung
damag
well
document
addit
widespread
lung
destruct
may
occur
spite
effect
antitubercul
therapi
subsequ
heal
may
result
extens
fibrosi
bronchostenosi
pleura
remodel
loss
pulmonari
volum
traction
bronchiectasi
accord
world
health
organ
cambodia
countri
highest
document
tb
preval
worldwid
popul
undertr
bacteri
infect
pulmonari
abscess
purul
pleurisi
may
also
caus
pulmonari
andor
pleural
sequela
final
bronchiectasi
may
result
acut
lower
respiratori
infect
alri
tubercul
sever
nontubercul
pathogen
highli
preval
cambodian
children
surveil
alri
sisea
project
surveil
investig
epidem
southeast
asia
conduct
two
cambodian
provinci
hospit
found
high
proport
pulmonari
sequela
diagnos
systemat
chest
radiograph
local
clinician
unawar
form
chronic
respiratori
diseas
e
absenc
systemat
microbi
identif
patient
deni
appropri
antibiot
usual
refer
special
tb
ward
standard
antitb
therapi
undertook
studi
describ
clinic
radiolog
microbiolog
characterist
patient
present
alri
postinfecti
pulmonari
sequela
alrip
includ
project
compar
type
alri
manag
alrip
patient
also
discuss
data
patient
studi
prospect
collect
communityacquir
alri
surveil
sisea
april
juli
two
provinci
cambodian
hospit
surveil
project
focus
alri
epidemiolog
cambodia
southeast
asian
tropic
countri
patient
recruit
assess
methodolog
describ
elsewher
sisea
approv
cambodian
nation
ethic
committe
health
research
number
patient
inform
consent
obtain
prior
investig
briefli
includ
inpati
lower
tract
respiratori
symptom
less
day
exclud
patient
known
immunodefici
hospit
physician
record
demograph
clinic
therapeut
data
well
onsit
biolog
test
result
outcom
assign
final
diagnosi
patient
includ
lung
sequela
superinfect
admiss
blood
noninduc
sputum
throat
nasopharyng
sampl
collect
direct
examin
cultur
molecular
diagnost
techniqu
perform
institut
pasteur
du
cambodg
procedur
viral
bacteri
assess
previous
describ
direct
sputum
examin
acidfast
bacilli
afb
perform
hospit
laboratori
patient
admiss
repeat
follow
two
day
accord
cambodia
nation
tb
recommend
cultur
systemat
perform
singl
chest
radiograph
per
patient
perform
admiss
expert
pulmonologist
blind
patient
condit
reinterpret
chest
radiograph
review
patient
medic
file
assign
final
diagnosi
includ
case
extract
sisea
databas
adult
patient
age
year
alri
abnorm
chest
radiograph
admiss
exclud
analysi
patient
respiratori
diseas
pulmonari
fibrosi
posttobacco
emphysema
pneumothorax
thorac
deform
thu
classifi
patient
three
group
alrip
alri
presum
previous
healthi
lung
alrihl
pulmonari
tb
final
exclud
patient
posit
afb
smear
pulmonari
sequela
avoid
confus
group
comparison
fig
alrip
group
defin
patient
clinic
biolog
sign
compat
alri
present
postinfecti
pulmonari
sequela
chest
radiograph
admiss
postinfecti
pulmonari
sequela
defin
radiologicallydiagnos
lung
lesion
highli
suggest
previou
lung
infect
tb
abscess
purul
pleurisi
bronchiectasi
sever
sequela
defin
least
combin
two
featur
retract
pleural
thicken
fibrosi
bronchiectasi
caviti
fig
illustr
sever
sequela
moder
sequela
defin
featur
taken
separ
alrihl
group
defin
patient
clinic
biolog
radiolog
sign
compat
pneumonia
pleurisi
pleuropneumonia
pulmonari
abscess
chest
radiograph
show
sign
postinfecti
sequela
recommend
pulmonari
tb
confirm
bacteriolog
diagnos
clinician
smearposit
smearneg
case
met
definit
definit
clinic
condit
diabet
renal
impair
cardiovascular
diseas
sever
describ
elsewher
firstlin
antibiotherapi
defin
antibiot
regimen
receiv
first
three
day
hospit
median
interquartil
rang
iqr
calcul
continu
data
number
percentag
determin
categor
data
characterist
patient
alrip
initi
compar
patient
alrihl
activ
pulmonari
tb
case
use
either
chisquar
nonparametr
test
kruskalew
appropri
identifi
clinic
risk
factor
superinfect
pulmonari
sequela
admiss
follow
variabl
p
valu
introduc
backward
stepwis
logist
regress
analysi
age
class
gender
comorbid
clinic
sign
sever
statist
signific
defin
threshold
p
odd
ratio
or
shown
variabl
remain
signific
within
final
model
analys
perform
use
stata
stat
corp
colleg
station
tx
usa
softwar
program
demograph
clinic
microbiolog
therapeut
characterist
alrip
among
patient
age
year
includ
surveil
project
case
abnorm
chest
radiograph
match
alri
definit
fig
among
tb
alrip
patient
sequela
associ
tb
exclud
analysi
fig
total
patient
final
elig
alrip
alrihl
tb
n
z
demograph
clinic
characterist
patient
summar
tabl
alrip
case
report
current
previou
tobacco
use
half
n
z
receiv
treatment
prior
admiss
patient
said
taken
antibiot
n
z
patient
product
cough
admiss
hemoptysi
chest
radiograph
show
major
sequela
patient
eleven
patient
sever
admiss
three
group
blood
cultur
sputum
sampl
obtain
patient
respect
main
pathogen
identifi
present
tabl
alrip
group
haemophilu
influenza
streptococcu
pneumonia
pseudomona
aeruginosa
account
posit
sputum
one
blood
cultur
h
influenza
strain
antibiot
suscept
test
result
produc
penicillinas
remain
suscept
amoxicillinclavulan
isol
strain
pneumonia
suscept
amoxicillin
p
aeruginosa
present
resist
except
ciprofloxacin
two
strain
concurr
viru
detect
note
patient
four
chest
radiograph
highli
suggest
aspergilloma
fungal
cultur
sputum
sampl
could
perform
firstlin
antibiot
prescrib
alrip
penicillin
patient
combin
aminoglycosid
patient
receiv
amoxicillinclavulan
avail
hospit
pharmaci
ceftriaxon
treatment
correctli
adapt
subsequ
avail
antibiot
suscept
test
result
patient
includ
patient
h
influenza
pneumonia
none
p
aeruginosa
klebsiella
pneumonia
median
durat
treatment
seven
day
iqr
day
median
length
stay
hospit
ten
day
iqr
day
total
six
patient
die
hospit
went
home
without
medic
discharg
accord
expert
review
alrip
recogn
local
clinician
patient
misdiagnos
tb
case
includ
transfer
anoth
hospit
anoth
ward
mainli
tb
ward
result
univari
analysi
shown
tabl
comparison
alrihl
tb
alrip
patient
significantli
older
age
year
fig
tabl
signific
differ
viru
yield
group
result
multivari
analysi
present
tabl
briefli
alrip
group
differ
alrihl
term
older
age
year
less
known
cardiovascular
diseas
diabet
less
fever
product
cough
hemoptysi
less
sever
admiss
comparison
tb
patient
patient
alrip
year
less
fever
hemoptysi
find
indic
clinician
public
health
specialist
littl
awar
burden
unrecogn
sequela
tbendem
countri
studi
nearli
one
four
adult
patient
admit
alri
present
superinfect
postinfecti
sequela
patient
mostli
age
chronic
pulmonari
diseas
often
advanc
associ
gramneg
bacilli
pneumonia
although
afb
smear
remain
neg
case
superinfect
sequela
misdiagnos
sometim
treat
activ
tb
furthermor
empir
firstlin
antibiot
treatment
use
inappropri
accord
antibiot
suscept
test
result
nearli
one
three
case
clinic
featur
help
distinguish
activ
tb
alrihl
alrip
patient
alrip
group
product
cough
less
often
febril
group
taken
individu
symptom
poor
clinic
indic
hemoptysi
preval
alrip
group
compar
group
unsurpris
due
frequenc
bronchiectasi
postinfecti
sequela
rel
high
proport
hemoptysi
alrihl
group
may
due
necrot
bacteria
k
pneumonia
b
pseudomallei
previous
describ
team
smearneg
tb
cambodia
smearneg
tb
account
tb
case
notifi
due
limit
cambodian
laboratori
facil
tb
cultur
avail
thu
studi
smearneg
tb
case
would
miss
h
influenza
pneumonia
p
aeruginosa
colon
airway
cours
noncyst
fibrosi
bronchiectasi
chronic
obstruct
pulmonari
diseas
elderli
acut
exacerb
chronic
obstruct
pulmonari
diseas
includ
bronchiectasi
exacerb
clearli
associ
presenc
bacteria
result
consist
studi
conduct
thailand
china
p
aeruginosa
haemophilu
influenza
also
two
frequent
pathogen
patient
steadyst
bronchiectasi
pseudomona
colon
bronchiectasi
associ
forc
expir
volum
declin
increas
cours
oral
antibiot
increas
hospit
admiss
subsequ
alter
qualiti
life
unfortun
spirometr
measur
avail
provinci
cambodian
hospit
studi
design
document
epidemiolog
mycolog
atyp
mycobacteria
fungi
aspergillu
spp
may
also
colon
bronchiectasi
preexistingcav
enhanc
hemoptysi
aspergilloma
erod
bronchial
arteri
short
preval
assess
prospect
studi
perform
among
consecut
patient
show
infect
nontubercul
mycobacteria
ie
mycobacterium
avium
intracellular
scrofulaceum
abscessu
fortuitum
mycobacterium
spp
least
one
three
consecut
sputum
sampl
institut
pasteur
cambodia
unpublish
data
patient
nine
present
alrip
shown
patient
bronchiectasi
posttb
sequela
higher
risk
chronic
respiratori
diseas
develop
nontubercul
mycobacteriosi
nevertheless
pathogen
atyp
mycobacteria
difficult
establish
studi
environment
contamin
exclud
clinician
howev
awar
diseas
could
overestim
tb
burden
develop
mycobacteria
cultur
identif
throughout
countri
could
help
address
issu
current
firstlin
empir
antibiot
use
alri
cambodia
penicillin
remain
activ
streptococcu
pneumonia
strain
found
alrip
group
howev
isol
h
influenza
p
aeruginosa
strain
resist
antibiot
cambodian
antibiot
guidelin
alri
current
revis
adjust
local
epidemiolog
theori
amoxicillinclavulan
ceftriaxon
cefotaxim
fluoroquinolon
possibl
choic
first
line
therapi
howev
two
major
obstacl
broad
use
fluoroquinolon
firstlin
empir
treatment
cambodia
one
hand
ofloxacin
ciprofloxacin
effect
antipneumococc
drug
p
aeruginosa
resist
ciprofloxacin
studi
hand
fluoroquinolon
current
remain
activ
tb
gener
fluoroquinolon
use
could
therefor
delay
tb
diagnosi
trigger
widespread
emerg
resist
tb
strain
sinc
present
alrip
patient
less
sever
admiss
fluoroquinolon
could
propos
group
secondlin
therapi
firstlin
treatment
found
ineffect
upon
reevalu
result
afb
screen
hospit
stay
longer
alrip
group
contribut
direct
indirect
cost
patient
famili
addit
low
percentag
mortal
studi
may
due
underreport
death
patient
frequent
die
home
discharg
alreadi
shown
anoth
cambodian
public
alri
patient
infect
k
pneumonia
vietnames
studi
hivtb
coinfect
patient
one
limit
studi
diagnosi
base
one
chest
radiograph
perform
admiss
sisea
project
lack
fund
perform
followup
radiolog
assess
radiograph
alrip
group
show
obviou
sequela
could
easili
recogn
clinician
howev
chest
radiograph
limit
sensit
detect
mild
abnorm
especi
bronchiectasi
case
mild
bronchiectasi
could
classifi
alrihl
group
thai
studi
bronchiectasi
patient
bronchiectasi
detect
comput
tomographi
ct
scan
normal
chest
radiograph
ct
scan
would
better
diagnosi
tool
chest
radiograph
case
unfortun
avail
cambodian
provinci
hospit
conclus
clinic
misdiagnosi
mismanag
superinfect
postinfecti
pulmonari
sequela
frequent
repres
seriou
threat
patient
public
health
healthcar
financ
tbhyperendem
countri
cambodia
improv
detect
chronic
bronchiti
sign
train
clinician
chest
radiograph
interpret
implement
mycobacteria
cultur
cambodian
laboratori
implement
use
simpl
spirometr
measur
could
help
diagnosi
studi
need
assess
declin
forc
expiratori
volum
reduct
longterm
function
prognosi
qualiti
life
cambodian
patient
addit
assess
gener
ad
cost
famili
cambodian
health
system
